Stock Price Quote

BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE27.041.28 (+4.97 %)
PREV CLOSE ( ) 25.76
OPEN PRICE ( ) 27.04
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1
TODAY'S LOW / HIGH ( )27.04 27.04
52 WK LOW / HIGH ( )5.25 27.04
NSE90.554.3 (+4.99 %)
PREV CLOSE( ) 86.25
OPEN PRICE ( ) 90.55
BID PRICE (QTY) 90.55 (999)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19185
TODAY'S LOW / HIGH( ) 81.95 90.55
52 WK LOW / HIGH ( )4.4 90.55
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1995
Management Info
Bafna Mahaveer Chand - Chairman Bafna Mahaveer Chand - Managing Director
Registered Office

Address Bafna Towers,New No 68, Old No.299,Thambu Chetty Street,
Chennai,
Tamil Nadu-600001

Phone 044- 25267517/25270992

Email cs@bafnapharma.com

Website www.bafnapharma.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE, MCX

NEWS

01Aug Bafna Pharmaceuticals informs about vo
Bafna Pharmaceuticals has informed that it has enclosed voting results f..
19Jan Bafna Pharmaceuticals submits sharehol
Bafna Pharmaceuticals has submitted the Shareholding Pattern for the Per..
24Nov Bafna Pharmaceuticals informs about co
Bafna Pharmaceuticals has informed that Radhakrishnan Dharmarajan has be..
21Jul Bafna Pharmaceuticals submits sharehol
Bafna Pharmaceuticals has submitted the Shareholding Pattern for the Per..
28May Bafna Pharmaceuticals’ unit gets renew
Bafna Pharmaceuticals’ facility has received renewal approval as per the..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit18.12-252.04
Gross Profit 18.12 -252.04
Operating Profit 27.7514.85
Net Sales 167.03424.72

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Valiant Organics (BSE)
peergroup  3502.50 (6.71%)
M.Cap ( in Cr)4755.25
Hester Biosciences (BSE)
peergroup  1843.00 (3.92%)
M.Cap ( in Cr)1567.82
Pfizer (BSE)
peergroup  5112.85 (1.00%)
M.Cap ( in Cr)23390.13
Torrent Pharma (BSE)
peergroup  2734.35 (0.74%)
M.Cap ( in Cr)46267.59
Ipca Laboratories (BSE)
peergroup  2173.00 (0.90%)
M.Cap ( in Cr)27564.96

Shareholding Pattern

PROMOTERS 92.64%
NON-INSTITUTION 7.36%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 27.04. Its current market capitalisation stands at Rs 63.97 Cr. In the latest quarter, company has reported Gross Sales of Rs. 424.73 Cr and Total Income of Rs.427.28 Cr. The company's management includes K Sabitha, Sunil Bafna, B Kamlesh Kumar, V Rajamani, Paras Bafna, Bafna Mahaveer Chand, Bafna Mahaveer Chand.

It is listed on the BSE with a BSE Code of 532989 , NSE with an NSE Symbol of BAFNAPH and ISIN of INE878I01022. It's Registered office is at Bafna Towers,New No 68, Old No.299,Thambu Chetty StreetChennai-600001, Tamil Nadu. Their Registrars are ACC Ltd. It's auditors are Abhay Jain & Co, R Sathyanarayanan & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)